Cargando…
The Marker State Space (MSS) Method for Classifying Clinical Samples
The development of accurate clinical biomarkers has been challenging in part due to the diversity between patients and diseases. One approach to account for the diversity is to use multiple markers to classify patients, based on the concept that each individual marker contributes information from it...
Autores principales: | Fallon, Brian P., Curnutte, Bryan, Maupin, Kevin A., Partyka, Katie, Choi, Sunguk, Brand, Randall E., Langmead, Christopher J., Tembe, Waibhav, Haab, Brian B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672150/ https://www.ncbi.nlm.nih.gov/pubmed/23750276 http://dx.doi.org/10.1371/journal.pone.0065905 |
Ejemplares similares
-
Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers
por: Yue, Tingting, et al.
Publicado: (2011) -
Detection of distinct glycosylation patterns on human γ-glutamyl transpeptidase 1 using antibody-lectin sandwich array (ALSA) technology
por: West, Matthew B, et al.
Publicado: (2014) -
Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9
por: Tang, Huiyuan, et al.
Publicado: (2015) -
Gaelic Medical Mss. and Their Authors
por: Mackinnon, Donald
Publicado: (1895) -
Gaelic Medical Mss. and Their Authors
por: Mackinnon, Donald
Publicado: (1895)